Table 5.
The effectiveness of each model in predicting the early recurrence of cHCC-CC
| Model | Training set | Testing set | Validation set | ||||||
|---|---|---|---|---|---|---|---|---|---|
| AUC | Sensitivity (%) | Specificity (%) | AUC | Sensitivity (%) | Specificity (%) | AUC | Sensitivity (%) | Specificity (%) | |
| Clinical model | 0.76 | 61.90 | 88.89 | 0.75 | 64.71 | 80.00 | 0.68 | 57.14 | 83.33 |
| CT model | 0.77 | 78.57 | 72.22 | 0.75 | 76.47 | 60.00 | 0.66 | 38.09 | 91.67 |
| Pathological model | 0.64 | 59.52 | 69.44 | 0.61 | 41.17 | 80.00 | 0.67 | 66.67 | 66.67 |
| clinic-CT model | 0.87 | 92.86 | 61.11 | 0.84 | 70.58 | 86.67 | 0.84 | 80.95 | 83.33 |
| Combined model | 0.89 | 83.33 | 77.78 | 0.85 | 76.47 | 80.00 | 0.86 | 80.95 | 83.33 |
AUC area under the curve